Delgocitinib Cream Reduces Itch and Pain in Moderate to Severe Chronic Hand Eczema: Phase 3 DELTA 1 and 2 Pooled Analyses
Early onset of itch/pain reduction was observed within week 1 for delgocitinib-treated patients, thereby providing further support of the use and efficacy of delgocitinib cream in adults with moderate to severe CHE.
Authors
- Keith Baranowski (ORCID: https://orcid.org/0009-0007-2333-0896)
- Marie-Louise S. Schuttelaar
- Ursula Plohberger (ORCID: https://orcid.org/0009-0005-7351-8825)
- Andréa Carla Bauer (ORCID: https://orcid.org/0000-0002-5041-4792)
- Margitta Worm
- Laura Sørensen
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- University Hospital Carl Gustav Carus (DE)
- Leo Pharma (Denmark) (DK)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1007/s13555-025-01611-y
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- LEO Pharma